Apoptosis of immature thymocytes mediated by E2/CD99

E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears to regulate adhesion properties of T cells as previously reported, in particular, the induction of homotypic adhesion in CD4+ CD8+ thymocytes. Apoptosis induced via E2/CD99 displays characteri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of immunology (1950) 1997-03, Vol.158 (6), p.2543-2550
Hauptverfasser: Bernard, G, Breittmayer, JP, de Matteis, M, Trampont, P, Hofman, P, Senik, A, Bernard, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2550
container_issue 6
container_start_page 2543
container_title The Journal of immunology (1950)
container_volume 158
creator Bernard, G
Breittmayer, JP
de Matteis, M
Trampont, P
Hofman, P
Senik, A
Bernard, A
description E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears to regulate adhesion properties of T cells as previously reported, in particular, the induction of homotypic adhesion in CD4+ CD8+ thymocytes. Apoptosis induced via E2/CD99 displays characteristic morphologic features, but includes early mitochondrial alterations and phosphatidylserine exposure at the outer leaflet of the plasma membrane. It is not followed by detectable DNA fragmentation, and its time course is much longer than apoptosis induced via the Fas/CD95 pathway. It requires 18 h for completion. E2/CD99-induced apoptosis does not require any RNA or protein synthesis and still occurs following blockage of the Fas pathway. It is, however, dependent on CPP32 and IL-1beta-converting enzyme-type cysteine proteases, as shown by blockade with their respective specific inhibitors. This effect is restricted to double-positive thymocytes carrying an intermediate density of CD3 and including all CD69+ cells. Thus, E2/CD99 apears to mediate a distinctive apoptotic signal at a critical stage of thymocyte differentiation, i.e., when positive selection is known to occur.
doi_str_mv 10.4049/jimmunol.158.6.2543
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78852785</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78852785</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-733c8b66b67fc03371f8e381ae44e528165c03237a2e4584a178cc67d5dc038f3</originalsourceid><addsrcrecordid>eNqFkE1LwzAYx4Moc04_gQg96ald3pMex5wvMPCi55Cmqetol9q0lH57MzrFm6cH_m_w_AC4RTChkKbLfVnX_cFVCWIy4QlmlJyBOWIMxpxDfg7mEGIcI8HFJbjyfg8h5BDTGZilkEkh2RzQVeOazvnSR66IwqDu-tZG3W6snRk766Pa5qXubB5lY7TBy_Vjml6Di0JX3t6c7gJ8PG3e1y_x9u35db3axoYK2sWCECMzzjMuCgMJEaiQlkikLaWWYYk4CzImQmNLmaQaCWkMFznLgy4LsgD3027Tuq_e-k7VpTe2qvTBut4rISXD4Y1_g4ilmEqJQ5BMQdM671tbqKYta92OCkF1hKp-oIaOVFwdoYbW3Wm-zwKO386JYvAfJn9Xfu6GsrXK17qqQhqpYRj-LH0DQt2ASQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15924882</pqid></control><display><type>article</type><title>Apoptosis of immature thymocytes mediated by E2/CD99</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bernard, G ; Breittmayer, JP ; de Matteis, M ; Trampont, P ; Hofman, P ; Senik, A ; Bernard, A</creator><creatorcontrib>Bernard, G ; Breittmayer, JP ; de Matteis, M ; Trampont, P ; Hofman, P ; Senik, A ; Bernard, A</creatorcontrib><description>E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears to regulate adhesion properties of T cells as previously reported, in particular, the induction of homotypic adhesion in CD4+ CD8+ thymocytes. Apoptosis induced via E2/CD99 displays characteristic morphologic features, but includes early mitochondrial alterations and phosphatidylserine exposure at the outer leaflet of the plasma membrane. It is not followed by detectable DNA fragmentation, and its time course is much longer than apoptosis induced via the Fas/CD95 pathway. It requires 18 h for completion. E2/CD99-induced apoptosis does not require any RNA or protein synthesis and still occurs following blockage of the Fas pathway. It is, however, dependent on CPP32 and IL-1beta-converting enzyme-type cysteine proteases, as shown by blockade with their respective specific inhibitors. This effect is restricted to double-positive thymocytes carrying an intermediate density of CD3 and including all CD69+ cells. Thus, E2/CD99 apears to mediate a distinctive apoptotic signal at a critical stage of thymocyte differentiation, i.e., when positive selection is known to occur.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.158.6.2543</identifier><identifier>PMID: 9058785</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>12E7 Antigen ; Antibodies, Monoclonal - pharmacology ; Antigens, CD - immunology ; Antigens, CD - physiology ; Antigens, Differentiation, T-Lymphocyte ; Apoptosis - immunology ; Caspase 1 ; Caspase 3 ; Caspases ; CD3 Complex ; CD4 Antigens ; CD8 Antigens ; Cell Adhesion Molecules - immunology ; Cell Adhesion Molecules - physiology ; Cell Differentiation - immunology ; Child, Preschool ; Cysteine Endopeptidases - drug effects ; Cysteine Proteinase Inhibitors - pharmacology ; fas Receptor - physiology ; Humans ; Immunophenotyping ; Jurkat Cells ; Lectins, C-Type ; T-Lymphocytes - immunology ; T-Lymphocytes - ultrastructure</subject><ispartof>The Journal of immunology (1950), 1997-03, Vol.158 (6), p.2543-2550</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-733c8b66b67fc03371f8e381ae44e528165c03237a2e4584a178cc67d5dc038f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9058785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bernard, G</creatorcontrib><creatorcontrib>Breittmayer, JP</creatorcontrib><creatorcontrib>de Matteis, M</creatorcontrib><creatorcontrib>Trampont, P</creatorcontrib><creatorcontrib>Hofman, P</creatorcontrib><creatorcontrib>Senik, A</creatorcontrib><creatorcontrib>Bernard, A</creatorcontrib><title>Apoptosis of immature thymocytes mediated by E2/CD99</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears to regulate adhesion properties of T cells as previously reported, in particular, the induction of homotypic adhesion in CD4+ CD8+ thymocytes. Apoptosis induced via E2/CD99 displays characteristic morphologic features, but includes early mitochondrial alterations and phosphatidylserine exposure at the outer leaflet of the plasma membrane. It is not followed by detectable DNA fragmentation, and its time course is much longer than apoptosis induced via the Fas/CD95 pathway. It requires 18 h for completion. E2/CD99-induced apoptosis does not require any RNA or protein synthesis and still occurs following blockage of the Fas pathway. It is, however, dependent on CPP32 and IL-1beta-converting enzyme-type cysteine proteases, as shown by blockade with their respective specific inhibitors. This effect is restricted to double-positive thymocytes carrying an intermediate density of CD3 and including all CD69+ cells. Thus, E2/CD99 apears to mediate a distinctive apoptotic signal at a critical stage of thymocyte differentiation, i.e., when positive selection is known to occur.</description><subject>12E7 Antigen</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Antigens, CD - immunology</subject><subject>Antigens, CD - physiology</subject><subject>Antigens, Differentiation, T-Lymphocyte</subject><subject>Apoptosis - immunology</subject><subject>Caspase 1</subject><subject>Caspase 3</subject><subject>Caspases</subject><subject>CD3 Complex</subject><subject>CD4 Antigens</subject><subject>CD8 Antigens</subject><subject>Cell Adhesion Molecules - immunology</subject><subject>Cell Adhesion Molecules - physiology</subject><subject>Cell Differentiation - immunology</subject><subject>Child, Preschool</subject><subject>Cysteine Endopeptidases - drug effects</subject><subject>Cysteine Proteinase Inhibitors - pharmacology</subject><subject>fas Receptor - physiology</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Jurkat Cells</subject><subject>Lectins, C-Type</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - ultrastructure</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LwzAYx4Moc04_gQg96ald3pMex5wvMPCi55Cmqetol9q0lH57MzrFm6cH_m_w_AC4RTChkKbLfVnX_cFVCWIy4QlmlJyBOWIMxpxDfg7mEGIcI8HFJbjyfg8h5BDTGZilkEkh2RzQVeOazvnSR66IwqDu-tZG3W6snRk766Pa5qXubB5lY7TBy_Vjml6Di0JX3t6c7gJ8PG3e1y_x9u35db3axoYK2sWCECMzzjMuCgMJEaiQlkikLaWWYYk4CzImQmNLmaQaCWkMFznLgy4LsgD3027Tuq_e-k7VpTe2qvTBut4rISXD4Y1_g4ilmEqJQ5BMQdM671tbqKYta92OCkF1hKp-oIaOVFwdoYbW3Wm-zwKO386JYvAfJn9Xfu6GsrXK17qqQhqpYRj-LH0DQt2ASQ</recordid><startdate>19970315</startdate><enddate>19970315</enddate><creator>Bernard, G</creator><creator>Breittmayer, JP</creator><creator>de Matteis, M</creator><creator>Trampont, P</creator><creator>Hofman, P</creator><creator>Senik, A</creator><creator>Bernard, A</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19970315</creationdate><title>Apoptosis of immature thymocytes mediated by E2/CD99</title><author>Bernard, G ; Breittmayer, JP ; de Matteis, M ; Trampont, P ; Hofman, P ; Senik, A ; Bernard, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-733c8b66b67fc03371f8e381ae44e528165c03237a2e4584a178cc67d5dc038f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>12E7 Antigen</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Antigens, CD - immunology</topic><topic>Antigens, CD - physiology</topic><topic>Antigens, Differentiation, T-Lymphocyte</topic><topic>Apoptosis - immunology</topic><topic>Caspase 1</topic><topic>Caspase 3</topic><topic>Caspases</topic><topic>CD3 Complex</topic><topic>CD4 Antigens</topic><topic>CD8 Antigens</topic><topic>Cell Adhesion Molecules - immunology</topic><topic>Cell Adhesion Molecules - physiology</topic><topic>Cell Differentiation - immunology</topic><topic>Child, Preschool</topic><topic>Cysteine Endopeptidases - drug effects</topic><topic>Cysteine Proteinase Inhibitors - pharmacology</topic><topic>fas Receptor - physiology</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Jurkat Cells</topic><topic>Lectins, C-Type</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - ultrastructure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bernard, G</creatorcontrib><creatorcontrib>Breittmayer, JP</creatorcontrib><creatorcontrib>de Matteis, M</creatorcontrib><creatorcontrib>Trampont, P</creatorcontrib><creatorcontrib>Hofman, P</creatorcontrib><creatorcontrib>Senik, A</creatorcontrib><creatorcontrib>Bernard, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bernard, G</au><au>Breittmayer, JP</au><au>de Matteis, M</au><au>Trampont, P</au><au>Hofman, P</au><au>Senik, A</au><au>Bernard, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Apoptosis of immature thymocytes mediated by E2/CD99</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>1997-03-15</date><risdate>1997</risdate><volume>158</volume><issue>6</issue><spage>2543</spage><epage>2550</epage><pages>2543-2550</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears to regulate adhesion properties of T cells as previously reported, in particular, the induction of homotypic adhesion in CD4+ CD8+ thymocytes. Apoptosis induced via E2/CD99 displays characteristic morphologic features, but includes early mitochondrial alterations and phosphatidylserine exposure at the outer leaflet of the plasma membrane. It is not followed by detectable DNA fragmentation, and its time course is much longer than apoptosis induced via the Fas/CD95 pathway. It requires 18 h for completion. E2/CD99-induced apoptosis does not require any RNA or protein synthesis and still occurs following blockage of the Fas pathway. It is, however, dependent on CPP32 and IL-1beta-converting enzyme-type cysteine proteases, as shown by blockade with their respective specific inhibitors. This effect is restricted to double-positive thymocytes carrying an intermediate density of CD3 and including all CD69+ cells. Thus, E2/CD99 apears to mediate a distinctive apoptotic signal at a critical stage of thymocyte differentiation, i.e., when positive selection is known to occur.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>9058785</pmid><doi>10.4049/jimmunol.158.6.2543</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 1997-03, Vol.158 (6), p.2543-2550
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_78852785
source MEDLINE; Alma/SFX Local Collection
subjects 12E7 Antigen
Antibodies, Monoclonal - pharmacology
Antigens, CD - immunology
Antigens, CD - physiology
Antigens, Differentiation, T-Lymphocyte
Apoptosis - immunology
Caspase 1
Caspase 3
Caspases
CD3 Complex
CD4 Antigens
CD8 Antigens
Cell Adhesion Molecules - immunology
Cell Adhesion Molecules - physiology
Cell Differentiation - immunology
Child, Preschool
Cysteine Endopeptidases - drug effects
Cysteine Proteinase Inhibitors - pharmacology
fas Receptor - physiology
Humans
Immunophenotyping
Jurkat Cells
Lectins, C-Type
T-Lymphocytes - immunology
T-Lymphocytes - ultrastructure
title Apoptosis of immature thymocytes mediated by E2/CD99
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T08%3A06%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Apoptosis%20of%20immature%20thymocytes%20mediated%20by%20E2/CD99&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Bernard,%20G&rft.date=1997-03-15&rft.volume=158&rft.issue=6&rft.spage=2543&rft.epage=2550&rft.pages=2543-2550&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.158.6.2543&rft_dat=%3Cproquest_cross%3E78852785%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15924882&rft_id=info:pmid/9058785&rfr_iscdi=true